BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial-Reference-Cited by-同舟云学术

BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial

Published:2024-10 Issue:4 Volume:89 Page:106245
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Messina Nicole L.,Pittet Laure F.,McDonald Ellie,Moore Cecilia,Barry Simone^ORCID,Bonten Marc,Byrne Anthony^ORCID,Campbell John^ORCID,Croda Julio,Croda Mariana G.,Dalcolmo Margareth,de Almeida e Val Fernando F.,de Oliveira Roberto D.,dos Santos Glauce,Douglas Mark W.,Gardiner Kaya^ORCID,Gwee Amanda,Jardim Bruno A.,Kollmann Tobias,Lacerda Marcus VG,Lucas Michaela^ORCID,Lynn David J.,Manning Laurens,Marshall Helen,O’Connell Abby,Perrett Kirsten P.,Post Jeffrey J.,Prat-Aymerich Cristina,Rocha Jorge L.,Rodriguez-Baño Jesus^ORCID,Wadia Ushma,Warris Adilia^ORCID,Davidson Andrew,Curtis Nigel

Publisher

Elsevier BV

Reference42 articles.

1. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review;Higgins;BMJ,2016

2. Early BCG-Denmark and neonatal mortality among infants weighing <2500 g: a randomized controlled trial;Biering-Sorensen;Clin Infect Dis,2017

3. Acute lower respiratory infection among Bacille Calmette-Guerin (BCG)-vaccinated children;Hollm-Delgado;Pediatrics,2014

4. Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis;de Castro;Clin Infect Dis,2015

5. BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial;Prentice;Lancet Infect Dis,2021